发明名称 IAP INHIBITORS
摘要 596669 Disclosed herein is a pyrrolo[3,2-b]pyrrole compound of formula (I), wherein the variables are defined in the specification, and the use thereof in the treatment of a cancer, such as sarcomas, bladder cancers, ovarian cancers, breast cancers, brain cancers, pancreatic cancers, colon cancers, blood cancers, skin cancers, lung cancers and bone cancers. Embodiments of the compound include the following: N,N'-bis-{ 2-[4-[3,3-dimethyl-2-(2-methylaminopropionylamino)-butyryl]-3-(4-fluoro-phenylcarbamoyl)-hexahydro-pyrrolo[3,2-b]pyrrol-1-yl]-2-oxo-ethyI} -oxalamide, and 4-[3,3-dimethyl-2-(2-methylamino-propionvlamino)-butyryl]-1-methanesulfonyl-octahydro-pyrrolo[3,2-b]pyrrole-3-carboxylic acid guinolin-2-ylamide.
申请公布号 NZ596669(A) 申请公布日期 2013.11.29
申请号 NZ20100596669 申请日期 2010.05.25
申请人 TETRALOGIC PHARMACEUTICALS CORP. 发明人 DENG, YIJUN;LAPORTE, MATTHEW, G
分类号 A01N43/36;A61K31/40;A61K31/407;C07D209/00 主分类号 A01N43/36
代理机构 代理人
主权项
地址